ARTICLE | Company News
BioLineRx, University of Illinois deal
July 30, 2007 7:00 AM UTC
The university granted BLRX an exclusive, worldwide license to develop and commercialize BL-4030, a preclinical apoptosis-inducing procaspase-3 activator. The timeline for Phase I testing and financi...